Dipyridamole for early-onset preeclampsia
Treatments studied
Part of Heart & circulation, Women’s health & pregnancy clinical trials.
This study tests whether dipyridamole, a blood thinner-like medicine, can help manage early-onset preeclampsia in pregnant women. It aims to see if the drug is safe and works to improve pregnancy outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are pregnant with one baby (not twins or more).
- You have been diagnosed with early-onset preeclampsia between 26 and 34 weeks of pregnancy.
- You are in the hospital for monitoring.
- Your doctor agrees that waiting and managing the condition is appropriate.
- Your blood tests show a high risk of preeclampsia (sFlt-1/PlGF ratio at least 85).
- Your baby is healthy without known major birth defects.
- Your platelet count is normal (at least 100,000).
- You do not have conditions that require immediate delivery or that increase bleeding risk.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking progesterone can improve outcomes for people with preeclampsia that is being managed without immediate delivery. It’s meant for pregnancies in a specific gestational age window and when both mother and baby are stable enough for “expectant management.”
This trial compares two doses of aspirin (75 mg vs 150 mg) in pregnant women at high risk for preeclampsia to see which dose works better to prevent the condition.
This trial studies whether extra screening in the first trimester for preeclampsia (dangerous blood pressure problems in pregnancy) can reduce health problems for both the mother and baby. You may be offered a screening plan that helps identify risk earlier so care can be adjusted.
This trial studies whether using specific blood-pressure medicines can help people with non-severe preeclampsia stay pregnant longer. It aims to improve outcomes by treating blood pressure early while monitoring you and the baby closely.
This trial tests whether taking aspirin during pregnancy around the time of delivery helps people with preeclampsia. You may be asked to take aspirin as part of a study plan, with monitoring to see how you do.
This trial tests a new medicine, CBP-4888, for pregnant women hospitalized with preeclampsia starting after 20 weeks. The goal is to see if it's safe and how it works for you and your baby, who will be followed for up to 24 months after birth.
Hear when a new Preeclampsia (PE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.